Playlist
The Hydrometeorological Service under the Ministry of Environmental Protection of Turkmenistan has released its latest weekly weather outlook. The forecast has been published in the newest issue of the “Turkmenistan” newspaper.
In Ashgabat, residents should expect partly cloudy skies accompanied by rainfall. Winds will shift from northwesterly to southeasterly directions, with speeds ranging between 10 and 16 m/s. Nighttime temperatures will vary from +7°C to +14°C, while daytime values will reach between +18°C and +28°C.
The Balkan region will experience similar conditions, with intermittent rain and increasing winds from northwest and east reaching 12–17 m/s. Night temperatures will range from +4°C to +15°C, while daytime highs may reach +23°C to +28°C, and slightly cooler +17°C to +22°C along coastal areas.
In Ahal, mixed cloud cover with rain is expected, along with winds of 7–15 m/s. Temperatures will range from +5°C to +16°C at night and from +16°C to +31°C during the day.
Mary region is likely to see rainfall mainly in the middle and toward the end of the week. Winds from southeast and northwest directions will reach up to 11–16 m/s. Night temperatures will range from +7°C to +17°C, and daytime temperatures from +19°C to +31°C.
Lebap will experience precipitation early in the week and again later on. Wind speeds will reach up to 12–17 m/s. Nighttime temperatures will range between +5°C and +16°C, and daytime temperatures between +17°C and +30°C.
Dashoguz is expected to receive rain mostly in the latter half of the week. Winds may strengthen up to 11–16 m/s. Temperatures will range from +4°C to +15°C at night and +16°C to +29°C during the day.
Also read
Simple Vitamin Shows Surprising Results in Pre-Cancerous Blood Conditions, Study Finds
Today in 02:02Daily high-dose supplementation of vitamin C can significantly reduce mortality risks and help prevent severe medical complications in patients with pre-cancerous blood conditions. Researchers from the Van Andel Institute in the United States and Copenhagen University Hospital in Denmark reached this conclusion following a comprehensive three-year follow-up study. The international "EVITA" trial involved volunteers who were administered 1,000 mg of vitamin C daily over the course of a year, while a control group received a placebo.
Although initial hypotheses suggested vitamin C might directly inhibit abnormal cell proliferation, researchers found its primary benefit lay in strengthening the body, reducing systemic inflammation, and lowering rates of anemia, pneumonia, and internal bleeding. Over the three-year observation period, the vitamin C group exhibited a significantly higher survival rate compared to the placebo group. While experts emphasize that these findings remain preliminary and require larger clinical trials before reshaping formal medical treatment protocols, vitamin C continues to show promising potential in supportive patient care.
Also read
Blitz